# CRIP1

## Overview
Cysteine-rich protein 1 (CRIP1) is a gene that encodes a member of the LIM/double zinc-finger protein family, characterized by its zinc-binding capabilities. The protein product, CRIP1, is involved in zinc transport and binding, particularly within the intestinal environment, and plays a significant role in zinc absorption and homeostasis (Khoo1997Human; Hempe1991Cysteinerich). Beyond its metabolic functions, CRIP1 is implicated in various cellular processes, including cell differentiation, proliferation, and signaling pathways such as Wnt/β-catenin, which are crucial for maintaining stem cell homeostasis and tissue regeneration (Paul2023Cysteinerich). CRIP1 also interacts with proteins involved in apoptosis and cannabinoid receptor signaling, highlighting its diverse roles in cellular regulation (Zhang2019Cysteinerich; Smith2015Cannabinoid). Clinically, CRIP1 expression is associated with various cancers, influencing disease progression and prognosis, making it a potential therapeutic target (Sun2021CRIP1; Liu2023CRIP1).

## Function
Cysteine-rich intestinal protein 1 (CRIP1) is a member of the LIM/double zinc-finger protein family, characterized by its zinc-binding capabilities, which are facilitated by a LIM domain comprising seven cysteines and one histidine. This domain is crucial for metal ion coordination, allowing CRIP1 to participate in zinc transport and binding, particularly in the intestine (Khoo1997Human). CRIP1 is highly expressed in the intestine and certain immune cells, where it plays a role in zinc absorption and homeostasis, potentially acting as an intracellular zinc carrier during transmucosal transport (Hempe1991Cysteinerich).

In addition to its role in zinc metabolism, CRIP1 is implicated in various cellular processes, including cell differentiation and proliferation. It is expressed in human peripheral blood mononuclear cells, suggesting a broader biological role beyond the intestine (Khoo1997Human). CRIP1 is also identified as a novel surface marker for human myometrial stem/progenitor cells, where it is involved in promoting cell migration, invasion, and epithelial-mesenchymal transition by activating the Wnt/β-catenin signaling pathway. This activity is crucial for maintaining stem cell homeostasis and may have implications in tissue regeneration and repair (Paul2023Cysteinerich).

## Clinical Significance
CRIP1 (cysteine-rich protein 1) has been implicated in various cancers, with its expression levels and interactions playing significant roles in disease progression and prognosis. In gastric cancer (GC), high CRIP1 expression is associated with poor survival outcomes and chemoresistance. CRIP1 enhances homologous recombination repair by stabilizing RAD51, which is crucial for DNA damage repair, thereby influencing the sensitivity of cancer cells to chemotherapy (Sun2021CRIP1).

In breast cancer, CRIP1 expression correlates with a more favorable prognosis and is linked to HER2-related oncogenesis. Knockdown of CRIP1 in breast cancer cell lines leads to increased cell proliferation and invasion, suggesting its role in regulating cell proliferation and survival (Ludyga2013The).

In pancreatic ductal adenocarcinoma (PDAC), CRIP1 is associated with poor prognosis and contributes to an immunosuppressive tumor microenvironment by facilitating the nuclear translocation of NF-κB/p65, which activates chemokines that recruit myeloid-derived suppressor cells (Liu2023CRIP1).

In colorectal cancer, CRIP1 promotes Fas protein degradation, reducing Fas-mediated apoptosis and potentially contributing to cancer progression (Zhang2019Cysteinerich). These findings highlight CRIP1's role in cancer biology and its potential as a therapeutic target.

## Interactions
Cysteine-rich protein 1 (CRIP1) is involved in various protein interactions that influence cellular processes. In colorectal cancer, CRIP1 interacts with the Fas protein, a transmembrane protein involved in apoptosis. This interaction leads to the down-regulation of apoptotic cascade-related proteins by reducing Fas expression at the protein level through ubiquitin-mediated degradation, although CRIP1 itself lacks ubiquitin ligase activity (Zhang2019Cysteinerich).

CRIP1a, a variant of CRIP1, interacts with the cannabinoid receptor CB1R. It binds to the C-terminal tail of CB1R, modulating its signaling and regulation. CRIP1a inhibits both constitutive and agonist-stimulated CB1R-mediated G-protein activity, affecting receptor internalization and G protein subtype accessibility (Oliver2020Cannabinoid; Smith2015Cannabinoid). CRIP1a also competes with β-arrestin for binding to CB1R, influencing receptor trafficking and internalization (Oliver2020Cannabinoid; Booth2019Cannabinoid).

CRIP1a's interaction with CB1R is specific to certain amino acids in the receptor's C-terminal domain, which are crucial for its regulatory effects on endocytosis (Mascia2017CRIP1a). These interactions highlight CRIP1's role in modulating receptor functions and cellular signaling pathways.


## References


[1. (Zhang2019Cysteinerich) Lanzhi Zhang, Rui Zhou, Weibin Zhang, Xueqing Yao, Weidong Li, Lijun Xu, Xuegang Sun, and Liang Zhao. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated fas degradation. Journal of Experimental &amp; Clinical Cancer Research, March 2019. URL: http://dx.doi.org/10.1186/s13046-019-1117-z, doi:10.1186/s13046-019-1117-z. This article has 27 citations.](https://doi.org/10.1186/s13046-019-1117-z)

[2. (Ludyga2013The) Natalie Ludyga, Sonja Englert, Kerstin Pflieger, Sandra Rauser, Herbert Braselmann, Axel Walch, Gert Auer, Heinz Höfler, and Michaela Aubele. The impact of cysteine-rich intestinal protein 1 (crip1) in human breast cancer. Molecular Cancer, April 2013. URL: http://dx.doi.org/10.1186/1476-4598-12-28, doi:10.1186/1476-4598-12-28. This article has 37 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-12-28)

[3. (Oliver2020Cannabinoid) Emily E. Oliver, Erin K. Hughes, Meaghan K. Puckett, Rong Chen, W. Todd Lowther, and Allyn C. Howlett. Cannabinoid receptor interacting protein 1a (crip1a) in health and disease. Biomolecules, 10(12):1609, November 2020. URL: http://dx.doi.org/10.3390/biom10121609, doi:10.3390/biom10121609. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom10121609)

[4. (Hempe1991Cysteinerich) J M Hempe and R J Cousins. Cysteine-rich intestinal protein binds zinc during transmucosal zinc transport. Proceedings of the National Academy of Sciences, 88(21):9671–9674, November 1991. URL: http://dx.doi.org/10.1073/pnas.88.21.9671, doi:10.1073/pnas.88.21.9671. This article has 76 citations.](https://doi.org/10.1073/pnas.88.21.9671)

[5. (Smith2015Cannabinoid) Tricia H. Smith, Lawrence C. Blume, Alex Straiker, Jordan O. Cox, Bethany G. David, Julie R. Secor McVoy, Katherine W. Sayers, Justin L. Poklis, Rehab A. Abdullah, Michaela Egertová, Ching-Kang Chen, Ken Mackie, Maurice R. Elphick, Allyn C. Howlett, and Dana E. Selley. Cannabinoid receptor–interacting protein 1a modulates cb1 receptor signaling and regulation. Molecular Pharmacology, 87(4):747–765, February 2015. URL: http://dx.doi.org/10.1124/mol.114.096495, doi:10.1124/mol.114.096495. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.114.096495)

[6. (Booth2019Cannabinoid) William T. Booth, Noah B. Walker, W. Todd Lowther, and Allyn C. Howlett. Cannabinoid receptor interacting protein 1a (crip1a): function and structure. Molecules, 24(20):3672, October 2019. URL: http://dx.doi.org/10.3390/molecules24203672, doi:10.3390/molecules24203672. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules24203672)

[7. (Mascia2017CRIP1a) Fabrizio Mascia, Lisa Klotz, Judith Lerch, Mostafa H. Ahmed, Yan Zhang, and Ralf Enz. <scp>crip</scp>1a inhibits endocytosis of g‐protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism. Journal of Neurochemistry, 141(4):577–591, April 2017. URL: http://dx.doi.org/10.1111/jnc.14021, doi:10.1111/jnc.14021. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/jnc.14021)

[8. (Paul2023Cysteinerich) Emmanuel N. Paul, Tyler J. Carpenter, Sarah Fitch, Rachael Sheridan, Kin H. Lau, Ripla Arora, and Jose M. Teixeira. Cysteine-rich intestinal protein 1 is a novel surface marker for human myometrial stem/progenitor cells. Communications Biology, July 2023. URL: http://dx.doi.org/10.1038/s42003-023-05061-0, doi:10.1038/s42003-023-05061-0. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-023-05061-0)

[9. (Sun2021CRIP1) Huiying Sun, Rui Zhou, Yannan Zheng, Zhaowei Wen, Dingling Zhang, Dongqiang Zeng, Jianhua Wu, Zhenhua Huang, Xiaoxiang Rong, Na Huang, Li Sun, Jianping Bin, Yulin Liao, Min Shi, and Wangjun Liao. Crip1 cooperates with brca2 to drive the nuclear enrichment of rad51 and to facilitate homologous repair upon dna damage induced by chemotherapy. Oncogene, 40(34):5342–5355, July 2021. URL: http://dx.doi.org/10.1038/s41388-021-01932-0, doi:10.1038/s41388-021-01932-0. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-021-01932-0)

[10. (Khoo1997Human) Christina Khoo, Raymond K. Blanchard, Vicki K. Sullivan, and Robert J. Cousins. Human cysteine-rich intestinal protein: cdna cloning and expression of recombinant protein and identification in human peripheral blood mononuclear cells. Protein Expression and Purification, 9(3):379–387, April 1997. URL: http://dx.doi.org/10.1006/PREP.1996.0709, doi:10.1006/prep.1996.0709. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/PREP.1996.0709)

[11. (Liu2023CRIP1) Xiaomeng Liu, Rong Tang, Jin Xu, Zhen Tan, Chen Liang, Qingcai Meng, Yubin Lei, Jie Hua, Yiyin Zhang, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, and Si Shi. Crip1 fosters mdsc trafficking and resets tumour microenvironment via facilitating nf-κb/p65 nuclear translocation in pancreatic ductal adenocarcinoma. Gut, 72(12):2329–2343, August 2023. URL: http://dx.doi.org/10.1136/gutjnl-2022-329349, doi:10.1136/gutjnl-2022-329349. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gutjnl-2022-329349)